Monthly Archives: September 2012

Study reveals effective preventive dose, pain drug for tuberculosis treatment, bad news and new steps in Uganda . . . and more

By on .

New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . .   NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]

Congressional compromise likely to give to global health with one hand, take with the other

By on .

Congress Poised to Pass Budget Bill to Keep Government Running Until Next Spring Congress is back in town but is unlikely to stay long as members consider a bill to fund federal government programs for 6 months – until March 27, 2013.   Passing this bill is essential to avoid a government shutdown on October 1—the […]

TB advocates respond to Global Fund proposal for “historical disease allocation” model

By on .

As board members of the Global Fund to Fight AIDS, Tuberculosis and Malaria prepare to meet Thursday and Friday in Geneva, advocates for tuberculosis detection, treatment and prevention have signed a response to a proposal they say will foster a divisive “disease against disease” approach to funding, and seriously undermine efforts to roll out cost-effective […]

Why response to drug-resistant tuberculosis lags, deadly disease in Togo prisons, while science leaps money lags . . .

By on .

Tuberculosis, Drug Resistance, and the History of Modern Medicine: From what may have been the first published randomized clinical drug trial, to  neglect when deaths declined in the affluent countries where “headlines are written,” to the widening fault lines that divided those who had to worry about tuberculosis, and those who could ignore it, to […]

Thai trial yield continues with news vaccine changed virus

By on .

The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]

AIDS Vaccine 2012: Of YECIs and generations of work

By on .

BOSTON, MA — When Bill Snow, now director of the Global HIV Vaccine Enterprise, first became interested in the quest for a vaccine against the AIDS virus, he had a life expectancy of less than 10 years, he said Sunday. That was in 1989, he told the audience gathered for the opening of AIDS Vaccine […]

HIV’s impact on men who have sex with men “can no longer be ignored”

By on .

More than 30 years into the epidemic that was first documented among gay men in America, a disturbing trend is being noted globally: Where rates of new HIV infections are going down among other populations, they are rising among men who have sex with men. “The epidemics are going in different directions,” said Chris Beyrer […]

AIDS Vaccine 2012 will highlight scope of promising prevention advances

By on .

With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers […]

Alarming but not surprising drug-resistant TB rates, survival sex, “a kind of truce,” and more . . .

By on .

Resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: This Lancet article looking at rates of  resistance to second line anti-tuberculosis drugs in Estonia, Latvia, Peru, Phillipines, Russia, South Africa, South Korea and Thailand, put numbers on a situation already known: tuberculosis is growing harder to cure. Following a June New England […]

Saying emphasis has been on output over impact, developing countries NGOs ask Global Fund: Help us make better use of the money

By on .

While the Global Fund to Fight AIDS Tuberculosis and Malaria looked at ways to restructure how it awards and administers grants, the Global Fund Board delegation representing nongovernmental organizations in developing countries conducted its own survey of obstacles in the field that have hindered  the best use of those grants. The result was a report […]